Belantamab mafodotin is under clinical development by GSK and currently in Phase I for Systemic Lupus Erythematosus.

On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on ...

INR:6527. satta satta matka GSK's first BCMA-targeted therapy Blenrep approved in Europe Shengxiang Bio's IPO registration on the Science and Technology Innovat ...

Hol n Win. INR:0679. gbleliciou Hol n Win GSK's first BCMA-targeted therapy Blenrep approved in Europe New standards for administrative penalties for pharmacies are her ...

football rules and regulations GSK's first BCMA-targeted therapy Blenrep approved in Europe Hengrui's two Category 1 new drugs were approved for clinical trials R&D Daily | Regeneron urgently stops ...

A multidisciplinary team, including McGregor Coxall, Haworth Tompkins, Studio Egret West, dRMM, Buro Happold, and Metropolitan Workshop, is working on plans to transform the former GSK headquarters in ...

GSK said on Friday the addition of its cancer drug Jemperli to both standard of care chemotherapy and Zejula maintenance ...

Particularly in oncology, while there is potential for approval and relaunch of Blenrep, challenges such ... GlaxoSmithKline (GSK) Company Description: In the pharmaceutical industry ...

This marks the first mesenchymal stromal cell therapy approved by the FDA for children with acute graft versus host disease. The Food and Drug Administration (FDA) approved Ryoncil (remestemcel-L-rknd ...

A 'lasting legacy' will be left by Glaxo Smith Kline when it closes its Ulverston site in 2025 after 75 years. A Task Force has been convened by local MP Michelle Scrogham to look at the support ...

The group will coordinate planning around future use of the site, the breadth of options for support to staff and agreeing next steps for the local investment of a £2m legacy donation by GSK.

GSK has acquired exclusive global rights to progress the clinical development and commercialisation of GSK’227. Credit: MAXSHOT.PL/Shutterstock. GlaxoSmithKline (GSK)’s B7-H3-targeted antibody-drug ...